Skip to main content
Caplight Logo









Creyon Bio

Creyon Bio

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://creyon.com/

Last Round

Strategic

Apr 29, 2025

Total Funding Raised

$40M

Company Overview

Creyon Bio is a biotechnology company that develops RNA-based medicines and their components using a data-first approach with machine learning models.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

AI drug discoveryRNA therapiesoligonucleotide therapiesdrug discovery platformtechbiooligo therapiespharma partnershipsoligo engineeringgenerative biologyquantum chemistryprecision medicineoligonucleotide-based medicinesOBMsaptamer delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Creyon Bio Comparables

Compare Creyon Bio with similar companies based on industry and business-model similarity.

Creyon Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Atomic AI
87%
Deep Genomics
87%
Genetic Leap
86%

Creyon Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 29, 2025
SeedMar 8, 2022

Key People

Founding team and executive leadership

Jason Ferrone

Chief Operating Officer And General Counsel

Executive Team

Creyon Bio Investors

Notable investors and investment history

Creyon Bio investors
InvestorRounds
DCVC BioSeed
Lux CapitalSeed
Alexandria Venture InvestmentsSeed
BioBritSeed
Casdin CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2025

    Completed a strategic funding round.

  • Mar 8, 2022

    $40M raised in Seed round.

Creyon Bio Filings

Explore SEC and related filing metadata, where available.

Creyon Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Creyon Bio's valuation, stock price, and market status.

Is Creyon Bio a public or private company?

Creyon Bio is a private company.

What is the current stock price of Creyon Bio?

Creyon Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Creyon Bio worth (valuation)?

Valuation information for Creyon Bio is not publicly available.

Can I buy Creyon Bio stock?

Creyon Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Creyon Bio's last funding round?

Creyon Bio's most recent funding round was Strategic on April 29, 2025.

Who are the main investors in Creyon Bio?

Key investors in Creyon Bio include DCVC Bio, Lux Capital.

Will Creyon Bio IPO soon?

No public IPO plans have been announced for Creyon Bio.

How can I track Creyon Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Creyon Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range28
Year Founded2019
Last FundingApr 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?